Source: ERJ Open Res 2015; 1: 00044-2015
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Gilchrist Francis J., Belcher John, Jones Andrew M., Smith David, Smyth Alan R., Southern Kevin W., Špan?l Patrik, Webb A. Kevin, Lenney Warren. Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis. ERJ Open Res 2015; 1: 00044-2015

Member's Comments

No comment yet.

Related content which might interest you: Detection of Pseudomonas aeruginosa in exhaled breath of cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 The sensitivity and specificity of pseudomonas aeruginosa detection using hydrogen cyanide concentration in exhaled breath – The SPACE study Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014 Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis Source: Eur Respir J 2011; 37: 553-558 Year: 2011 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 Does sputum induction improve Pseudomonas aeruginosa detection in cystic fibrosis? Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003 Bacterial cyanogenesis occurs in the cystic fibrosis lung Source: Eur Respir J 2008; 32: 329-333 Year: 2008 Exhaled pentane – a new breath test in cystic fibrosis? Source: Annual Congress 2006 - New developments in infant and intensive care lung function Year: 2006 Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients Source: Eur Respir J 2008; 32: 740-747 Year: 2008 Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004 Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings Source: Eur Respir J 2004; 24: Suppl. 48, 157s Year: 2004 Exhaled hydrogen sulfide in patients with chronic airway inflammatory disease Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis Source: Eur Respir J 2013; 42: 1723-1736 Year: 2013 Increased IL-8 in exhaled breath condensate in cystic fibrosis during acute exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 Correlation analysis of the colonization by Pseudomonas aeruginosa and genetic polymorphism of nitric oxide synthases in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 727s Year: 2005 Exhaled breath temperature in adult cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis Source: Eur Respir J 2004; 24 : 631-637 Year: 2004 Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017 Year: 2017 Breath condensate is acidified during infective exacerbations in children with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 527s Year: 2002